Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

Review

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

       
Total article views   HTML views PDF downloads Totals
8,607 Dovepress* 6,299+ 1,398 7,697
PubMed Central* 2,308 490 2,798
Totals 8,607 1,888 10,495
*Since 3 December 2019

View citations on PubMed and Google Scholar